These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
379 related articles for article (PubMed ID: 19667650)
41. The metabolic syndrome: in need of a global mission statement. Cameron AJ; Zimmet PZ; Shaw JE; Alberti KG Diabet Med; 2009 Mar; 26(3):306-9. PubMed ID: 19317827 [TBL] [Abstract][Full Text] [Related]
43. The cardiometabolic syndrome in the adolescent. Gardner M; Gardner DW; Sowers JR Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():964-8. PubMed ID: 18806711 [TBL] [Abstract][Full Text] [Related]
44. Hyperinsulinaemia, a key factor of the metabolic syndrome in postmenopausal women. Gaspard U Maturitas; 2009 Apr; 62(4):362-5. PubMed ID: 19131194 [TBL] [Abstract][Full Text] [Related]
46. Reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering: a role for fenofibrate. Introduction. Sacks FM Am J Cardiol; 2008 Dec; 102(12A):1L-3L. PubMed ID: 19084082 [No Abstract] [Full Text] [Related]
47. Prevalence of the metabolic syndrome in US populations. Ford ES Endocrinol Metab Clin North Am; 2004 Jun; 33(2):333-50. PubMed ID: 15158522 [TBL] [Abstract][Full Text] [Related]
51. New insights into understanding cardiometabolic risk. Introduction. Fonarow GC; Watson KE Rev Cardiovasc Med; 2007; 8 Suppl 4():S1-2. PubMed ID: 17934389 [No Abstract] [Full Text] [Related]
52. Metabolic syndrome: psychosocial, neuroendocrine, and classical risk factors in type 2 diabetes. Abraham NG; Brunner EJ; Eriksson JW; Robertson RP Ann N Y Acad Sci; 2007 Oct; 1113():256-75. PubMed ID: 17513461 [TBL] [Abstract][Full Text] [Related]
53. Does the metabolic syndrome add to the diagnosis and treatment of cardiovascular disease? de Zeeuw D; Bakker SJ Nat Clin Pract Cardiovasc Med; 2008 Jul; 5 Suppl 1():S10-4. PubMed ID: 18580860 [TBL] [Abstract][Full Text] [Related]
54. The metabolic syndrome as a risk factor for venous and arterial thrombosis. Dentali F; Squizzato A; Ageno W Semin Thromb Hemost; 2009 Jul; 35(5):451-7. PubMed ID: 19739035 [TBL] [Abstract][Full Text] [Related]
55. Fenofibrate for cardiovascular disease prevention in metabolic syndrome and type 2 diabetes mellitus. Steiner G Am J Cardiol; 2008 Dec; 102(12A):28L-33L. PubMed ID: 19084087 [TBL] [Abstract][Full Text] [Related]
56. Cardiovascular risk assessment in metabolic syndrome: view from PROCAM. Assmann G; Nofer JR; Schulte H Endocrinol Metab Clin North Am; 2004 Jun; 33(2):377-92, table of contents. PubMed ID: 15158524 [TBL] [Abstract][Full Text] [Related]
57. Psoriasis and the metabolic syndrome. Gottlieb AB; Dann F; Menter A J Drugs Dermatol; 2008 Jun; 7(6):563-72. PubMed ID: 18561588 [TBL] [Abstract][Full Text] [Related]
58. Metabolic syndrome: at the crossroads of cardiorenal risk. Natali A; Pucci G; Boldrini B; Schillaci G J Nephrol; 2009; 22(1):29-38. PubMed ID: 19229816 [TBL] [Abstract][Full Text] [Related]
59. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Grundy SM; Hansen B; Smith SC; Cleeman JI; Kahn RA; ; ; Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):e19-24. PubMed ID: 14766740 [No Abstract] [Full Text] [Related]
60. Metabolic syndrome in the prevention of cardiovascular diseases and diabetes--still a matter of debate? Ma X; Zhu S Eur J Clin Nutr; 2013 May; 67(5):518-21. PubMed ID: 23403882 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]